Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.736 USD | -2.57% | -3.99% | -18.85% |
Financials (USD)
Sales 2024 * | 96M | Sales 2025 * | - | Capitalization | 171M |
---|---|---|---|---|---|
Net income 2024 * | -129M | Net income 2025 * | -204M | EV / Sales 2024 * | 2.48 x |
Net Debt 2024 * | 67.55M | Net Debt 2025 * | 127M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.32
x | P/E ratio 2025 * |
-0.96
x | Employees | 135 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.05% |
Latest transcript on Gossamer Bio, Inc.
1 day | -2.17% | ||
1 week | -3.94% | ||
Current month | +4.35% | ||
1 month | -25.91% | ||
3 months | -14.84% | ||
6 months | +34.71% | ||
Current year | -18.81% |
Managers | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Bryan Giraudo
DFI | Director of Finance/CFO | 48 | 18-05-06 |
Chief Tech/Sci/R&D Officer | - | 23-10-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Faheem Hasnain
CEO | Chief Executive Officer | 65 | 15-10-24 |
Thomas Daniel
BRD | Director/Board Member | 69 | 17-12-31 |
Skye Drynan
BRD | Director/Board Member | - | Mar. 10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-09 | 0.7399 | -2.05% | 728 702 |
24-05-08 | 0.7554 | +3.27% | 4,245,939 |
24-05-07 | 0.7315 | -6.30% | 2,115,496 |
24-05-06 | 0.7807 | +5.50% | 8,510,626 |
24-05-03 | 0.74 | -4.06% | 4,329,555 |
Delayed Quote Nasdaq, May 09, 2024 at 11:07 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.81% | 171M | |
+25.16% | 46.71B | |
+48.83% | 41.8B | |
-1.18% | 41.52B | |
-3.42% | 29.55B | |
+10.30% | 25.78B | |
-20.87% | 19.26B | |
+0.64% | 12.14B | |
-1.40% | 12.08B | |
+26.81% | 11.98B |
- Stock Market
- Equities
- GOSS Stock